Elinogrel

INNOVATE PCI: Intravenous and Oral Elinogrel vs. Clopidogrel as a Novel Antiplatelet Therapy in Patients Undergoing Non-Urgent PCIs

      -Trial Results by Dr. Sunil Rao (ESC 2010)

 

PRT060128

      -Oral Dosing of PRT060128, a Novel Direct-acting, Reversible P2Y12 Antagonist Overcomes High Platelet Reactivity in Patients Non-responsive to Clopidogrel Therapy by Dr. Paul Gurbel

 

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster